Registered entities
BRIDGENE BIOSCIENCES INC
Reg. No. 830552264United States
BridGene Biosciences, Inc.
Reg. No. 83-0552264United States
Innovation
9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 232 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 5 |
Social engagement
Social engagement: 5.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Kaitai Capital Management, Lapam Capital, Deyi Capital, Junson Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Private equity | 2 | 20% |
| Angel & family office | 1 | 10% |
| Other / undisclosed | 2 | 20% |
Recent activity
5 Jun 2026
Event
BIO 2026
12 Mar 2026
Event
BIO-Europe Spring 2026
14 Jan 2026
Partnership
Lilly team through TuneLab